Hanmi Pharm closer to Celltrion in market capitalization

Published: 2015-11-11 15:47:54

Updated: 2015-11-11 16:05:37

Hanmi Pharm has exceeded KRW 8 trillion in market capitalization from a series of technology exports.

It has gotten closer by KRW 200 billion to the leading market capitalization(KRW 8.626 trillion) in the pharmaceutical and biopharmaceutical industry, owned by Celltrion; Hanmi is about to become the new leader in the field.

Hanmi Pharm recorded KRW 8.4303 trillion market capitalization in th...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.